Skip to main content
TipRanks
Go Ultimate75% OFF

Syndax Pharmaceuticals (1T3) Ownership - Who Owns Syndax Pharmaceuticals?

4 Followers

Syndax Pharmaceuticals (1T3) Ownership Overview

  • 1.59% Insiders
  • 17.30% Mutual Funds
  • 55.60% Other Institutional Investors
  • 14.44% ETFs
  • 11.08% Public Companies and Individual Investors

The ownership structure of Syndax Pharmaceuticals (DE:1T3) stock is a mix of institutional, retail, and individual investors. Approximately 87.34% of the company’s stock is owned by Institutional Investors, 1.59% is owned by Insiders, and 11.08% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Jun 01, 2026Keith Goldan$22,351
Jun 01, 2026Michael Metzger$130,025
Feb 09, 2026Keith Goldan$71,678
Feb 09, 2026Michael Metzger$360,682

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Woodline Partners Lp€26,276,534

Top Shareholders

DE:1T3 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.9,268,460Institution10.30%79,838,514
Ishares4,413,030Institution4.90%38,013,840
Vanguard4,118,359Institution4.57%35,475,544
Vanguard Index Funds3,837,471Institution4.26%33,055,975
James E. Flynn3,779,900Institution4.20%32,560,059
Spdr2,940,682Institution3.27%25,331,035
Franklin Strategic Series1,510,840Institution1.68%13,014,376
Fidelity Salem Street Trust1,334,283Institution1.48%11,493,514
Michael Rockefeller1,330,805Institution1.48%11,463,554
Dennis J Purcell1,316,806Institution1.46%11,342,967

Top Mutual Fund Holders

DE:1T3 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds3,837,471Institution4.26%33,055,975
Franklin Strategic Series1,510,840Institution1.68%13,014,376
Fidelity Salem Street Trust1,334,283Institution1.48%11,493,514
Manager Directed Portfolios1,211,108Institution1.35%10,432,484
Tiaa-cref Funds1,030,397Institution1.14%8,875,840
Fidelity Concord Street Trust860,637Institution0.96%7,413,527
Vanguard Scottsdale Funds614,737Institution0.68%5,295,345
Delaware Group Equity Funds Iv540,000Institution0.60%4,651,560
Blackrock Funds500,114Institution0.56%4,307,982
Loomis Sayles Funds Ii499,843Institution0.56%4,305,648

FAQ

Who Owns Syndax Pharmaceuticals (DE:1T3)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 87.34% of the company's stock is held by institutional investors, 1.59% is held by insiders, and 11.08% is held by public companies and individual investors.
What percentage of Syndax Pharmaceuticals (DE:1T3) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 87.34% of Syndax Pharmaceuticals (DE:1T3) stock is held by institutional investors: 17.30% by mutual funds, 14.44% by ETFs and 55.60% by other institutional investors.
What percentage of Syndax Pharmaceuticals (DE:1T3) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 11.08% of Syndax Pharmaceuticals (DE:1T3) stock is held by public companies and individual investors.
Who owns the most shares of Syndax Pharmaceuticals (DE:1T3)?
BlackRock, Inc. owns the most shares of Syndax Pharmaceuticals (DE:1T3).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.